|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.68 USD | -3.70% |
|
-0.47% | +18.80% |
| Market Cap | 1.49B 1.3B 1.21B 1.11B 2.09B 142B 2.13B 14.23B 5.59B 70.92B 5.6B 5.48B 238B | P/E 2026 * |
-3.38x | P/E 2027 * | -6.29x |
|---|---|---|---|---|---|
| Enterprise Value | 1.14B 989M 920M 845M 1.6B 109B 1.62B 10.85B 4.26B 54.05B 4.27B 4.18B 181B | EV / Sales 2026 * |
19.2x | EV / Sales 2027 * | 3.98x |
| Free-Float |
96.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Intellia Therapeutics, Inc.
| 1 day | -3.70% | ||
| 1 week | -0.47% | ||
| 1 month | -38.05% | ||
| 3 months | -19.46% | ||
| 6 months | -18.78% | ||
| Current year | +18.80% |
| 1 week | 10.15 |  | 11.31 |
| 1 month | 10.15 | | 18.11 |
| Current year | 9.05 | | 18.48 |
| 1 year | 7.95 | | 28.25 |
| 3 years | 5.9 | | 40.98 |
| 5 years | 5.9 | | 180.59 |
| 10 years | 5.9 | | 202.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 68 | 2017-12-31 |
Edward Dulac
DFI | Director of Finance/CFO | 51 | 2024-07-21 |
Kristy Wood
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Leonard
BRD | Director/Board Member | 68 | 2014-06-30 |
Frank Verwiel
CHM | Chairman | 63 | 2020-01-31 |
Jesse Goodman
BRD | Director/Board Member | 74 | 2018-10-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/22/26 | Sell | Chief Financial Officer | -8,111 | 0.0058% | ||
| 7/2/26 | Sell | Chief Financial Officer | -4,677 | 0.0033% | ||
| 7/1/26 | Sell | Controller/Auditor | -2,641 | 0.0019% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.70% | -0.47% | -7.05% | -73.93% | 1.49B | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | |
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | |
| Average | -1.72% | +0.90% | +54.47% | +71.02% | 25.19B | |
| Weighted average by Cap. | -1.61% | +2.02% | +79.23% | +107.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 59.37M 51.61M 48.04M 44.1M 83.28M 5.67B 84.57M 566M 222M 2.82B 223M 218M 9.46B | 274M 238M 221M 203M 384M 26.12B 390M 2.61B 1.02B 13B 1.03B 1.01B 43.6B |
| Net income | -412M -358M -333M -306M -578M -39.31B -587M -3.93B -1.54B -19.57B -1.55B -1.51B -65.62B | -230M -200M -186M -171M -323M -22B -328M -2.2B -863M -10.95B -865M -846M -36.72B |
| Net Debt | -355M -309M -287M -264M -498M -33.88B -506M -3.38B -1.33B -16.87B -1.33B -1.3B -56.56B | -402M -350M -325M -299M -564M -38.38B -573M -3.84B -1.51B -19.11B -1.51B -1.48B -64.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$10.68 | -3.70% | 2,650,733 |
| 26-07-30 | US$11.09 | +2.69% | 3,183,984 |
| 26-07-29 | US$10.80 | -0.83% | 3,489,846 |
| 26-07-28 | US$10.89 | +2.06% | 4,859,991 |
| 26-07-27 | US$10.67 | -0.56% | 2,892,763 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NTLA Stock
Select your edition
All financial news and data tailored to specific country editions
